Glyscend
Glyscend is dedicated to the development of a truly revolutionary approach to treating type 2 diabetes. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
AUD127—190m (Dealroom.co estimates Jun 2020.)
Baltimore Maryland (HQ)
Authorizing premium user...